Integer Holdings Corporation (ITGR)
NYSE · Healthcare · Medical Devices
$126.450.00%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $4.3B
- P/E (trailing)
- 34.5
- Forward P/E
- 18.4
- 52-week range
- $62.00 – $126.80
- 52-week change
- +19.99%
- EPS (trailing)
- $3.66
- Next earnings
- Oct 29, 2026
Fiscal year to Dec 2025
- Revenue
- $1.9B (+7.98%)
- Net income
- $103M
- Operating margin
- 11.9%
- Diluted EPS
- $2.89
- Free cash flow
- $105M
From the company’s annual report on SEC EDGAR.
About Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies.
Headquarters: Plano, United States · 11,000 employees · integer.net